Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Health119-hr1796 — Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025. Sponsored by Rep. James, John [R-MI-10]. Introduced 2025-03-03. House bill. 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce.
- Sponsor
- Rep. James, John [R-MI-10] (R), MI
- Introduced
- 2025-03-03
- Committees
- Energy and Commerce Committee
- Subjects
- Blood and blood diseases; Genetics; Health promotion and preventive care; Hereditary and development disorders; Medical research; Research administration and funding
- Latest Action
- Referred to the House Committee on Energy and Commerce.
No roll-call vote data available for this bill.
Similar Bills
- 119-s735 — Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 91% match
- 118-hr3884 — H.R. 3884, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 82% match 118th Congress
- 118-s1852 — S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 79% match 118th Congress
- 115-hr2410 — Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018 61% match 115th Congress
- 113-hr5124 — Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2014 50% match 113th Congress
Investigate this bill →
Beneficiary scoring, topic classification, and fiscal analysis